HomeACAD • NASDAQ
add
ACADIA Pharmaceuticals Inc
Previous close
$18.55
Day range
$18.55 - $19.05
Year range
$14.55 - $32.59
Market cap
3.12B USD
Avg Volume
1.79M
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
In the news
Financials
Income Statement
Revenue
Net income
(USD) | Mar 2024info | Y/Y change |
---|---|---|
Revenue | 205.83M | 73.75% |
Operating expense | 107.99M | 6.67% |
Net income | 16.56M | 138.48% |
Net profit margin | 8.04 | 122.14% |
Earnings per share | 0.10 | 137.04% |
EBITDA | 20.74M | 139.01% |
Effective tax rate | 21.17% | — |
Balance Sheet
Total assets
Total liabilities
(USD) | Mar 2024info | Y/Y change |
---|---|---|
Cash and short-term investments | 470.52M | 16.79% |
Total assets | 855.10M | 30.49% |
Total liabilities | 391.06M | 39.14% |
Total equity | 464.04M | — |
Shares outstanding | 165.22M | — |
Price to book | 6.60 | — |
Return on assets | 4.74% | — |
Return on capital | 7.51% | — |
Cash Flow
Net change in cash
(USD) | Mar 2024info | Y/Y change |
---|---|---|
Net income | 16.56M | 138.48% |
Cash from operations | 29.08M | 262.15% |
Cash from investing | -14.04M | -107.29% |
Cash from financing | 1.04M | -28.85% |
Net change in cash | 16.09M | -90.86% |
Free cash flow | 77.56M | 8.36% |
About
Acadia Pharmaceuticals Inc. is a biopharmaceutical company headquartered in Sorrento Valley, San Diego, California. Wikipedia
Founded
1993
Headquarters
Website
Employees
610